Owen Hughes compensation by year
Cullinan Therapeutics Summary Compensation Table · all 3 fiscal years held| Component | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Salary | $450,000 | $461,250 | $433,279 |
| Bonus | $96,800 | $245,063 | $216,507 |
| Stock awards | $0 | $530,320 | $0 |
| Option awards | $0 | $5,301,175 | $6,005,982 |
| Non-equity incentive | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $14,000 | $14,250 | $130,419 |
| Total | $560,800 | $6,552,058 | $6,786,187 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cullinan Therapeutics, Inc. DEF 14A filed April 29, 2022, accession 0001193125-22-130030, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Cullinan Therapeutics, Inc. filed document, accession 0001193125-22-130030. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.
Cullinan Therapeutics’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Nadim Ahmed | President and Chief Executive Officer | $38,547,200 |
| Owen Hughes · this page | Former President and Chief Executive Officer | $6,786,187 |
| Patrick Baeuerle | Acting Chief Scientific Officer, Biologics | $4,675,977 |
| Jeffrey Trigilio | Chief Financial Officer | $2,667,277 |
The full Cullinan Therapeutics compensation record
free company briefThis page is one person within Cullinan Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cullinan Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.